PharmD, PhD
Service d’Hématologie biologique, AP-HP, Hôpital européen Georges-Pompidou, F-75015, Université Paris Cité, Inserm, PARCC, F-75015 Paris, France
Paris, Ile-de-France, France
Laetitia MAUGE, PharmD-PhD currently in the Department of Biological Haematology of the Georges Pompidou European Hospital (HEGP), Faculty of Medicine Paris Cité University and PARCC-INSERM U970.
Hospital activity mainly focused on haemostasis with a specialization in the diagnosis of inherited thrombophilia, plasmatic and genetic exploration of antithrombin, proteins C and S deficiencies. Research activity also directed on the role of angiogenesis in the response to antiangiogenic or immunotherapy in renal cancer (in the INSERM U970, team «Immunotherapy and anti-angiogenic treatment in cancer»).
Member of the French Study Group in Haemostasis and the French Society of Angiogenesis .
PB0994 - Intronic exploration of PROC in patients with unexplained protein C deficiencies.
Monday, June 26, 2023
18:30 – 19:30 ET
PB0997 - Utility of Thrombin Generation Assay for inherited thrombophilia screening
Monday, June 26, 2023
18:30 – 19:30 ET
Tuesday, June 27, 2023
18:30 – 19:30 ET